The treatment discontinuation and interruption criteria for nivolumab using National Cancer Institute Terminology Criteria for Adverse Events version 5.0.
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
The treatment discontinuation and interruption criteria for nivolumab using National Cancer Institute Terminology Criteria for Adverse Events version 5.0.
创建时间：
2024-04-18
